On December 5, 2022 Endoluxe reported that it has entered into a know-how agreement with Mayo Clinic to research the use of artificial intelligence and machine learning in the fight against bladder cancer (Press release, Mayo Clinic, DEC 5, 2022, View Source [SID1234624814]). Mayo Clinic will utilize the Endoluxe Visualization System, a wireless endoscopic "smart" camera platform, and its unique edge computing attributes, which provide AI-powered clinical insights to clinicians and can lead to better patient outcomes.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The novel Endoluxe technology platform provides clinicians real-time data and clinical insights onscreen during a surgical procedure–an important tool that no other endoscopic platform currently offers.

"Working with Mayo Clinic clinicians will further advance Endoluxe’s surgical insights capabilities. We are excited to accelerate our cutting-edge technology platform for the benefit of patients," said Dr. Phil Zhao, Chief Medical Officer at Endoluxe.